LH Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
3.8B
+2.1%
3.7B
+5.5%
3.5B
+0.6%
3.5B
-1.3%
3.6B
Cost of Revenue
2.7B
+3.2%
2.6B
+3.8%
2.5B
+0.0%
2.5B
-0.6%
2.5B
Gross Profit
1.1B
-0.4%
1.1B
+9.7%
1.0B
+2.1%
993.2M
-3.1%
1.0B
Operating Expenses
706.0M
+6.9%
660.4M
+4.3%
633.0M
-12.8%
725.6M
+15.4%
628.5M
R&D
0
0
0
0
0
SG&A
611.4M
+5.9%
577.2M
+4.8%
551.0M
+2.3%
538.6M
-2.6%
553.1M
Operating Income
402.1M
-11.0%
451.6M
+18.6%
380.8M
+42.3%
267.6M
-32.5%
396.6M
EBITDA
601.0M
-5.5%
635.7M
+13.4%
560.5M
+1.0%
555.0M
-3.2%
573.5M
Net Income
263.1M
-12.0%
299.1M
+7.6%
278.0M
+68.6%
164.9M
-36.9%
261.5M
EPS (Basic)
$3.24
-11.5%
$3.66
+8.6%
$3.37
+69.3%
$1.99
-36.6%
$3.14
EPS (Diluted)
$3.22
-11.5%
$3.64
+8.7%
$3.35
+69.2%
$1.98
-36.5%
$3.12
Shares (Diluted)
81.6M
-0.5%
82.0M
-1.1%
82.9M
-0.5%
83.3M
-0.5%
83.7M
Lab (LH) — Financials